← All Bridgebio Pharma, INC filings

Bridgebio Pharma, INC Form 4 insider transactions

NASDAQ
BBIO
Bridgebio Pharma, INC
Form 4: BridgeBio Pharma CFO Brian Stephenson Reports Stock Transactions
Brian Stephenson, CFO of BridgeBio Pharma, reports the vesting and subsequent tax withholding of shares related to restricted stock units.
NASDAQ
BBIO
Bridgebio Pharma, INC
Form 4: BridgeBio Pharma CEO Neil Kumar Acquires Stock Options and Restricted Stock Units
CEO Neil Kumar reports acquisition of stock options and restricted stock units in BridgeBio Pharma, Inc.
NASDAQ
BBIO
Bridgebio Pharma, INC
Form 4: BridgeBio Pharma CFO Brian Stephenson Reports Stock Option and Restricted Stock Unit Grants
Brian Stephenson, CFO of BridgeBio Pharma, reports the acquisition of stock options and restricted stock units.
NASDAQ
BBIO
Bridgebio Pharma, INC
Form 4: BridgeBio Pharma Director Randal W. Scott Sells Shares Under 10b5-1 Plan
Director Randal W. Scott sold 2,500 shares of BridgeBio Pharma, Inc. common stock at $34 per share on March 1, 2024, under a pre-arranged 10b5-1 trading plan.